Henry Schein, Inc.
NASDAQ:HSICMedical - Distribution
-$1.24 today
- Market cap
- $9.47B
- Beta
- 0.82
- P/E (TTM)
- 23.3
- EPS (TTM)
- $3.44
Volume 2.08M
Average 1.39M
HSIC Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Henry Schein, Inc.NASDAQ: HSIC
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation growth accelerates
Q2 FY2026 stock-based compensation of $13M rose 18.2% year over year, ahead of the -17.1% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 333.3% from the prior quarter.
Context
- Stock-based compensation amounted to 0.0% of revenue in FY2025, down 0.3 pp from a year earlier.
- Stock-based compensation increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +18.2% holds above the trailing-twelve-month pace of -17.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-27 | 0 | -100.0% |
| FY2024 | 2024-12-28 | 39M | +0.0% |
| FY2023 | 2023-12-31 | 39M | -27.8% |
| FY2022 | 2022-12-31 | 54M | -30.8% |
| FY2021 | 2021-12-31 | 78M | — |
Stock-Based Compensation vs competitors
How HSIC compares with its peers on the latest reported figures
- HSIC's LTM Jun 2026 stock-based compensation of $29M is the 3rd largest of the 7 companies compared; the peer median is $10.92M.
- Its year-over-year change of -17.1% is the 2nd highest of 6, against a peer median of -57.9%.
- Stock-based compensation amounts to 0.2% of revenue for HSIC, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $383M | +24.8% | +56.4% | 0.1% | |
| LTM Jun 2026 | $122.79M | -50.8% | +16.6% | 0.0% | |
| LTM Jun 2026 | $29M | -17.1% | — | 0.2% | |
| LTM Mar 2026 | $16M | -57.9% | -17.6% | 0.4% | |
| LTM Mar 2026 | $5.84M | -78.3% | -15.0% | 0.2% | |
| LTM Oct 2026 | $2.3M | -91.5% | +7.2% | 0.1% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding HSIC) | $10.92M | -57.9% | +7.2% | 0.1% | |
Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 660.53M | 566M | 416M | 398M | 398M |
| Depreciation & Amortization | 209.53M | 212M | 222M | 268M | 311M |
| Deferred Income Tax | (12.93M) | (61M) | 0 | (56M) | 5M |
| Stock-Based Compensation | 78M | 54M | 39M | 39M | 0 |
| Change in Working Capital | (197.2M) | (281M) | (234M) | 140M | (48M) |
| Accounts Receivables | 4.16M | (7M) | (327M) | 315M | (124M) |
| Inventory | (295.13M) | (126M) | 231M | (59M) | (95M) |
| Accounts Payables | 84.71M | (96M) | 0 | (163M) | 216M |
| Other Working Capital | 9.06M | (52M) | (138M) | 47M | (45M) |
| Other Non-Cash Items | (28.34M) | 112M | 57M | 59M | 46M |
| Operating Cash Flow | 709.58M | 602M | 500M | 848M | 712M |
| Capital Expenditures | (79.02M) | (96M) | (187M) | (187M) | (139M) |
| Acquisitions (Net) | (560.8M) | (158M) | (955M) | (230M) | (276M) |
| Purchases of Investments | (7.32M) | (11M) | 0 | 0 | 0 |
| Sales of Investments | 7.32M | 11M | 22M | 4M | 0 |
| Other Investing Activities | (37.4M) | (22M) | (55M) | (56M) | (10M) |
| Investing Cash Flow | (677.22M) | (276M) | (1.14B) | (430M) | (477M) |
| Debt Repayment | 165M | 259M | 900M | 189M | 551M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 252M |
| Common Stock Repurchased | (401M) | (485M) | (284M) | (385M) | (850M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (88.96M) | (57M) | 85M | (314M) | (64M) |
| Financing Cash Flow | (332.96M) | (315M) | 701M | (510M) | (111M) |
| Effect of Forex Changes | (2.63M) | (12M) | (12M) | 43M | (90M) |
| Net Change in Cash | (303.22M) | (1M) | 54M | (49M) | 34M |
| Free Cash Flow | 630.57M | 506M | 313M | 661M | 573M |
Henry Schein, Inc.
NASDAQ:HSIC
Intrinsic Alpha fair value
Locked
Current Price
$85.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.